Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer's disease.
David Howlett(King's College London), Ishrut Hussain(GlaxoSmithKline (United Kingdom)), Stephen A. Burbidge(GlaxoSmithKline (United Kingdom)), A Lawman, Gianluca Miglio(University of Turin), Jill Richardson(GlaxoSmithKline (United Kingdom)), Emma L. Dawson, Peter E. Soden(GlaxoSmithKline (United Kingdom)), María Isabel González, J B Davis, Elaine Irving, E R Howlett, K. Bowler, David Riddell(Eli Lilly (United States))
Cited by 66
Related Papers
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
|Nature|2011|1.5k
ApoE Promotes the Proteolytic Degradation of Aβ
|Neuron|2008|869
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|Human Molecular Genetics|2008|479
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor
|Journal of Medicinal Chemistry|2012|460
Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease
|Archives of General Psychiatry|2010|402